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Abstract
Background: While it is known that a variety of factors (biological, behavioural and interventional) play a major role
in the health of individuals and populations, the importance of the role of social determinants is less clear. The
effect of social inequality on population-based screening for colorectal cancer (CRC) could limit the value of such
programmes. The present study aims to determine whether such inequalities exist.
Methods: Data was obtained from the population-based screening programme administered in the Autonomous
Community of the Basque Country, Spain, with a target population aged 50 to 69, first invited to participate
between 2009 and 2011. The magnitude of inequality was analysed using the odds ratio (taking the least
disadvantaged socioeconomic quintile as the reference population), the population attributable risk and the relative
index of inequality, based on the regression, which is the ratio of the rates in the most and least disadvantaged
socioeconomic groups.
Results: The target population comprised 242,394 people, with the test kit successfully sent to 95.1 % (230,510).
The overall response rate was 64.3 % (67.1 in women and 61.4 % men).
Among women, the highest participation was in the third quintile (71.5 %) and the lowest in the first – the least
disadvantaged (65.7 %). The lowest and highest rates of people with identified lesions were in the second and
fourth quintiles (14.7/1000 and 17.0/1000 respectively).
Among men, the response rate was lowest in the fifth – most disadvantaged – quintile (60.2 %). The highest rate of
identified lesions was in the fifth quintile; 38 % higher than the first (55.7/1000 compared to 41.0/1000).
Conclusions: Sex and socioeconomic group influence the rate of participation in the CRC programme and the rate
of lesions found in the participants.
Any public health programme is morally and ethically obliged to strive for equity and effectiveness. Improving
participation of men and socially disadvantaged groups should be taken in account.
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Background
The health of individuals and populations depends on a
wide range of factors, including biological variables,
health-related behaviour and health system performance.
There is growing evidence, however, that social determi-
nants of health play a highly important role [1, 2]. The
uneven distribution of these determinants according to
different social stratification criteria - social class, educa-
tional level, degree of deprivation of area of residence,
etc. - generates health inequalities, with those belonging
to more disadvantaged socioeconomic groups or living
in areas of greater social deprivation consistently eviden-
cing worse health indicators and unhealthier lifestyles
and habits [3–5].
The WHO Commission on Social Determinants of
Health (CSDH) said in its 2008 report [1] that the
organization and characteristics of health systems also
play an important role in health equity, either reducing
inequalities generated by other social determinants or,
conversely, amplifying them. The “inverse care law”,
according to which the availability of health care tends
to vary inversely with the need of the target population
[6, 7], is a well-identified mechanism for explaining the
amplification phenomenon. Despite their universal ap-
proach, population-based disease prevention and health
promotion programmes implemented by health author-
ities do not always guarantee equal access for and im-
pact on the various social groups, which can lead to a
worsening of social inequalities in health [8]. Some pos-
tulate reduced responsiveness to disease prevention and
health promotion messages among people living in dis-
advantaged socioeconomic areas - due to competition
from or prioritization of more essential needs - while
others identify reduced availability and implementation
of programmes in such contexts [9].
Specifically, health-system-driven population screening
programmes (including population-based CRC screen-
ing) help decrease the impact of certain diseases or
health problems on the population, through early detec-
tion. The aim is to reduce the incidence of progressive
disease and related mortality, which are high in all devel-
oped countries. According to WHO estimates CRC af-
fected over 471.240 people in 2012, with almost 228.275
dying from the disease in the European Union. In Spain,
CRC is in first place for incidence (32,240 people) and
takes second place for mortality (14,700 deaths), out-
numbered only by deaths from lung cancer [10]. Basque
Country data follows the same trend, with a significant
increase in incidence in the last two decades [11].
The ability of screening to reduce CRC mortality de-
pends heavily on the degree of participation in the popu-
lation, but also on the chosen screening method. A
faecal occult blood test (FOBT) performed every two
years can reduce mortality by 19 %, whereas first-line
colonoscopy offers a 68 % reduction [12]. The guaiac-
based FOBT has now been replaced by the faecal immu-
nochemical test (FIT), thus increasing test sensitivity,
and colonoscopy has improved in terms of equipment,
training and quality assurance [13]. In Spain, according
to National Cancer Strategy, FOBT every two years is
recommended for 50–69 years old population and col-
onoscopy as a confirmatory test in positive cases, being
included as a basic service for all population in 2014 [14].
With regard to participation, the literature shows that
even in well-established programmes with high popula-
tion coverage, significant social inequalities exist, by so-
cioeconomic status, gender, age and ethnicity [15–22].
Women (perhaps due to their greater awareness of the
importance of self-care, as well as their role as the
household's main caregiver) and older people (>60) show
the highest screening rates [15–17], while men evidence
greater participation in invasive tests [18]. Most studies
agree that the main causes of non-participation among
the most disadvantaged socioeconomic groups are: lack
of information about the disease, prioritization of other
problems with a greater impact on everyday life, and not
understanding the written communications that arrive in
the post [15, 16].
In 2013, 11 of Spain's 17 regions had population-based
CRC screening programmes in place, which, when com-
bined, covered 20 % of the Spanish population aged be-
tween 50 and 69 [23]. The Basque Country was the
region with the greatest coverage (97.9 %) in 2013, com-
bined with high participation (64.3 %) [24], being their
target population around 583,000 people, which 51.4 %
are women. This can be attributed to a Primary Care
programme that began in 2009, based on the use of a
two-yearly FIT, with those patients that returned a posi-
tive FIT referred to the public hospital for colonoscopy
under sedation, in order to confirm the diagnosis. A
strategy of home delivery of testing kits combined with
provision of a broad time band for delivering the sam-
ples to health centres was implemented to facilitate par-
ticipation, as well as detailed programme information
and access to a freephone information service. However,
the potential existence of social inequalities in the vari-
ous phases of screening may limit the effectiveness of
the programme and bring the “inverse care law” into
play. The aim of this article is thus to describe the magni-
tude of social inequalities in population-based CRC
screening in the Basque Country between 2009 and 2011,
according to the level of socioeconomic deprivation of the
area of residence, focusing mainly on response rates and
lesions identified. This data was reported with regard to
sex in a previous publication [25]. Nowadays, the
programme is continuing rolling-out with the same cri-
teria inviting progressively in successive rounds all the tar-
get population.
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Methods
This is a cross-sectional study of people aged 50 to
69 years invited to participate for the first time in the
Basque Country’s CRC screening programme between
2009 and 2011. The study was approved by the Euskadi
Ethics Committees and each participant provided writ-
ten informed consent.
Study subjects
People aged 50 to 69, living in the Basque Country and
registered with one of the 60 health centres in which the
CRC screening programme was implemented between
2009 and 2011, equivalent to about 50 % of the region's
population in the given age range. The population cov-
ered by the programme at that time was not complete
because of the colonoscopy capacity in hospitals was
limited then. Exclusion criteria were: being under surveil-
lance for previously diagnosed CRC, having a high-risk
family history of CRC, or having colonoscopy/sigmoidos-
copy follow-up for adenoma during the previous 5 years,
or total colectomy or terminal/irreversible disease or un-
known address.
Study variables
Successfully-invited population
People aged 50–69 years meeting no exclusion criteria,
who were sent a letter of invitation that was not returned
due to the address being incorrect.
Participant
Of all those who were successfully invited, those who
handed in the kit and for whom a correct result was
returned (negative/positive).
Positive FIT test
20 ng/ml according to manufacturer's instructions. OC-
Sensor (2009–2011) and Sentinel (2009–2010) were used.
People with premalignant lesion, defined as the dis-
covery after colonoscopy of advanced (medium- and
high-risk) adenomas, as defined in the 2010 European
Guidelines [26] and malignant lesion invasive carcin-
oma (≥pT1) according to the pathology report in the
patient record.
Source of data
Socioeconomic status
Each study participant was assigned the socioeconomic
deprivation index (DI) of their small area of residence.
This composite index was calculated by the Basque
Government Health Department's Health Research Ser-
vice, using the Medea Project [26] criteria, from simple
indicators in the 2001 Census: unemployment, manual
workers, casual workers, insufficient education and in-
sufficient education among young people. The DI was
divided into quintiles, with the first being the least disad-
vantaged and the fifth the most disadvantaged. Partici-
pant data was linked to the DI variable using the
Individual Health Card code, or the corporative identifica-
tion code, in those cases where the participant did not
have an Individual Health Card number. The DI was
successfully assigned to 95.1 % of participants, while ad-
dress information quality did not permit to link the
remaining 4.9 %.
All data was obtained from the Basque Country's
population-based CRC screening programme database,
which is linked to patient records. This allows all cases
to be followed, from submission of the sample, through
analysis, colonoscopy, pathology and follow-up.
Statistical analysis
Age-standardized rates were calculated using the direct
method for the different variables, for total participants
and by level of deprivation, using Basque Country resi-
dents between 50 and 69 years in 2011 as the reference
population. To obtain participation rates, the number of
people who participated was divided by the successfully-in-
vited population. To obtain lesion rates, the number of
people in whom lesions were detected was divided by the
total participant population. To obtain malignant lesion
rates, the number of people in whom malignant lesions
were detected was divided by the total participant popula-
tion. To obtain the positive predictive value (PPV), the
number of people with lesions detected was divided by the
number of people with positive FIT results. The compara-
tive analysis between men and women was performed
using indirectly standardized ratios and between age
groups, using odds ratios estimated by logistic regression
models. The magnitude of inequalities was analysed using:
(a) odds ratios estimated by logistic regression models,
taking as the reference population the least disadvantaged
socioeconomic quintile, (b) the population-attributable
risk (PAR) and (c) the relative index of inequality (RII). RII
is based on the regression and consists of the rate ratio
between the most and least disadvantaged groups respect-
ively. These results were estimated using logistic regres-
sion models. All analyses were performed separately for
men and women. P value less than 0.05 was considered
statistically significant using 2-sided test. The analysis was
performed with R v. 2.13.1.
Results
Between 2009 and 2011, the target population comprised
242,394 people (50.9 % women), with the test kit success-
fully sent to 230,510 (95.1 %). Of this group, a DI was
successfully assigned to 219,120 people (95.1 %) (Fig. 1).
The overall response rate was 64.3 % (67.1 in women
and 61.4 % men). In 6.7 % of participants, the FIT result
was positive (4.8 of women and 9.0 % of men). Of these,
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92.6 % were given a colonoscopy (92.0 of women and
93.0 % of men), resulting in the detection of 4,523 le-
sions, of which 3,952 were premalignant and 571 were
carcinomas, with 383 in stages I-II (Table 1).
Among participants, the standardized rate of people
with lesions was 48.5/1000 in men, three times higher
than the 15.7/1000 for women. The rate of people with
malignant lesions was also 2.34 times higher in men
than women (5.49/1000 vs. 2.42/1000). The PPV of the
test was 52.2 % in men compared to 32.5 % in women
(Table 2).
Both men and women aged 60–64 participated most
in the programme, while those between 50–54 ages par-
ticipated least. Lesion detection rates and people with
malignant rates were higher in the older age groups. The
rate of people with cancer in stages III and IV only
increased with age in men (p < 0.001).
Among men, the PPV of the test increased with age,
ranging from 43.60 % to 59.67 %. Among women, the
lowest and the highest PPV were 31.62 % (50–54) and
33.01 (65–69), respectively.
The proportion of people who underwent a colonos-
copy following a positive FIT result was not associated
with age (Table 3).
By socioeconomic status, among women, the highest
percentage participation was in the third quintile
(71.5 %) and the lowest participation was in the - least
disadvantaged - first quintile (65.7 %). This quintile also
underwent the lowest colonoscopy rate following a posi-
tive FIT result (89.1 %). The lowest and highest rates of
people with lesions identified were in the second and
fourth quintiles respectively (14.7/1000 compared to
17.00/1000), although overall the effect of socioeco-
nomic status was not statistically significant (p =0.600).
Neither did the DI show any statistically significant as-
sociation with the rate of people with malignant lesions
(p = 0.824), rate of people with cancer in stages III and
IV (p = 0.853), or the PPV (p = 0.197). No RII was
calculated in women, since on reviewing the tables; no
linear association was visible between the DI and the
results (Table 4).
The PAR or percentage of preventable lesions if the
total rates had been those of the DI quintile with the
lowest lesion rate is 6.7 % in women, representing 81
fewer lesions if the rate of people with lesions for the
whole population had been that of the second quintile.
Among men, the participation rate was significantly
lower in the fifth – most disadvantaged – quintile
(60.2 %) compared to other quintiles. The first quintile
had the smallest proportion of people who underwent a
colonoscopy after a positive result (90.5 %), followed by
the fifth quintile (92.5 %), with the fourth quintile show-
ing the largest (95.6 %). The rates of people with lesions
identified were highest in the fifth quintile and were
38 % higher than those in the first quintile (55.7/1000
compared to 41.0/1000). The highest rate of malignant
lesions was in the third quintile (6.9/1000), although this
was not significantly higher than the reference quintile
(OR 1.25, 95 % CI (0.92-1.69)). No significant association
was found with the rate of people with cancer in stages
III and IV (p = 0.137) or with the PPV (p = 0.349). The
RII for the rate of men with lesions (premalignant and
malignant) was 1.37 (95 % CI 1.21-1.55) (Table 4).
The PAR or percentage of preventable lesions in men
was 16.0 %, which is equivalent to 529 fewer people with
lesions if the overall rate had been that of the DI quintile
with the lowest rate (first quintile).
Finally, if a rate similar to that obtained in the quintile
with the highest rate of participation (71.5 % of women
in the third quintile) had been achieved in all socioeco-
nomic quintiles, 466 people with lesions would have
been detected within this period (414 men), of which 56
would have been malignant (48 men).
Discussion
This study reveals socioeconomic inequalities in a number
of quality indicators for the Basque Country's colorectal
cancer screening programme between 2009 and 2011.
Target population
242,394
Excluded by other 
pathologies or because 
they are being monitored 
for a previously 
diagnosed CRC
5,222
Population to whom
you send the 
invitation letter
237,072
Returned
invitations
6,562
Population 
successfully-invited
230,510
Could not be 
assigned a DI 
quintile
11,390
Finally invited 
population with a 
DI quintile assigned
219,120
Fig. 1 Flowchart
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Men in the most disadvantaged socioeconomic class
evidence the lowest participation rate, but also the high-
est rates of premalignant and malignant lesions, between
23 and 55 % higher than the least disadvantaged quintile.
Among women, those in the groups with the lowest and
highest socioeconomic status participate the least, and no
differences are observed in the rate of people with lesions
in the most disadvantaged groups. No differences in PPV
are detected between socioeconomic groups, either in
men or in women, and neither are there any differences
between groups in the percentage of colonoscopies per-
formed after a positive FIT result.
Overall participation rate (64.3 %) is close to the 65 %
target set by the 2011 European Guidelines [26], although
it is lower in men than in women, and lower in the youn-
gest and oldest groups. A similar pattern is found in other
CRC screening programmes [15, 19, 27–29].
Attempting to explain this differential behaviour by
sex and age, some studies postulate that men might be
less interested about their health, as well as being afraid
of the diagnostic test, while women might assume the
role of caregiver, leading more of them to worry about
their health, for the sake of those around them [15, 16].
The influence of a dominant societal perception of mas-
culinity has been described as an important factor in
explaining inferior participation among men, since CRC
screening entails the risk of having to undergo an inva-
sive procedure - colonoscopy- that might conflict with
normative “male” beliefs [30, 31]. In younger people,
feeling healthy and less vulnerable to the disease could
be a barrier to participation. Finally not being aware of
the importance of screening or not having had their doc-
tor recommend the screening process are some factors
that might reduce participation in the older age groups
Table 1 Baseline table with data and distribution percentages
Totals % Women % Men %
Population 242,394 122,901 119,493
age (years):
50-54 81,605 33.7 41,065 33.4 40,540 33.9
55-59 59,633 24.6 30,130 24.5 29,503 24.7
60-64 61,266 25.3 31,176 25.4 30,090 25.2
65-69 39,890 16.5 20,530 16.7 19,360 16.2
Successfully-invited population, out of the total population 230,510 97.2 117,573 97.6 112,937 96.8
Participants, out of the successfully-invited population 148,265 64.3 78,916 67.1 69,349 61.4
FOBT results for participants
Positive 9,961 6.7 3,751 4.8 6,210 9.0
Negative 138,165 93.2 75,091 95.2 63,074 91.0
Error 130 0.1 71 0.1 59 0.1
Lost 9 0.0 3 0.0 6 0.0
colonoscopy performed after positive FOBT
No 735 7.4 300 8.0 435 7.0
Yes 9,226 92.6 3,451 92.0 5,775 93.0
Colonoscopy results
Negative 4,639 50.3 2211 64.1 2,428 42.0
N/A or inconclusive 64 0.7 20 0.6 44 0.8
Premalignant or malignant lesion 4,523 49.0 1220 35.4 3,303 57.2
Type of premalignant or malignant lesion:
Premalignant 3,952 87.4 1,034 84.8 2,918 88.3
Cancer 571 12.6 186 15.2 385 11.7
Cancer results:
stage I/II 383 67.1 118 63.4 265 68.8
stage lII/IV 181 31.7 65 34.9 116 30.1
stage unknown / N/A 6 1.1 2 1.1 4 1.0
stage lost 1 0.2 1 0.5 0 0.0
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[15, 16]. These hypothetical explanations should be
treated with caution, however, since it is widely recog-
nised that knowledge and health beliefs have a limited
capacity to explain people's actual behaviour, and under-
lying motives are particularly difficult to ascertain [32].
The rate of people with premalignant and malignant
lesions detected in colonoscopy is three times higher in
men than in women. In the older group, it is 2.6 and 1.7
times higher than the younger group, for men and
women respectively (5.02 and 2.4 times higher in the
older group if we only take into account rates of people
with malignant lesions). These figures corroborate the
strong association of age and sex with the probability of
detecting a premalignant or malignant lesion that has
been reported in other studies [33–36].
The PPV for detection of premalignant and malignant
lesions increases with age and is significantly higher in
men than in women. These patterns are already known
and are probably due in large part to differences in
prevalence between certain subgroups [37–39].
The proportion of colonoscopy performed following a
positive FIT result was not associated with age in either
sex. Similar results were found by other authors (36-steel,
44-Dupont-Lucasa). The high compliance of the proced-
ure in all the age groups (above 91.5 %) could have played
a role in the lack of association.
In both sexes the socioeconomic groups with the low-
est participation were, paradoxically, both the least and
the most disadvantaged. The former could be due to
greater access to private healthcare among the more
privileged social classes. In fact public health services are
available for all population, but the least deprived nor-
mally contract a private insurance as well, where colonos-
copy is offered as an opportunistic screening. As already
noted above, in reference to the research by Williams,
explaining low participation among the most disadvan-
taged social classes is not a simple task. Lifestyles are com-
posed mostly of actions performed automatically without
forethought, with habits and the pursuit of social distinc-
tion being the key factors for explaining health and
lifestyle, which accounts for the substantial gap between
health knowledge and behaviour [32]. Caution is required,
therefore, when assessing specific explanations postulated
in other articles, such as greater fear of screening, the per-
ception that it is harder to perform, doubts over whether
screening is beneficial, lack of knowledge about the test,
difficulty in understanding written information and lack of
social support [15, 16, 19, 20].
While the published results of other screening pro-
grammes show that a lower proportion of those from
more disadvantaged social strata attended for colonos-
copy after a positive FIT result, it is not the case here
[35, 40–42]. Participation among disadvantaged socio-
economic groups is a sign of good programme imple-
mentation. Dupont-Lucas et al., in a study that also
showed no socioeconomic differences in the percentage of
colonoscopies after a positive test, suggest that the volun-
tary nature of the programme (which is also the case in
the present example) allows those members of disadvan-
taged social groups who would not have been willing to
undergo colonoscopy to opt out [43]. On the contrary, the
least deprived quintiles show the lowest percentage of col-
onoscopy for diagnostic confirmation, possibly because a
greater proportion are able to access private clinics, whose
data is not available to the current study.
The premalignant and malignant lesion detection rates
show an inverse association with socioeconomic status
in men but not in women. The influence of socioeco-
nomic status on the incidence of CRC is not clear in the
literature. Recent systematic reviews and large prospect-
ive studies show mixed results. While it appears that in
the United States and Canada, lower socioeconomic status
is associated with higher rates of CRC, especially in the
proximal colon, the tendency in Europe seems to be in the
opposite direction, i.e., lower incidence of CRC in lower
socioeconomic strata [44–46]. Studies with a higher inci-
dence of CRC among lower socioeconomic strata or those
with less education, point to a higher prevalence of modi-
fiable risk factors associated with CRC such as smoking,
excessive alcohol consumption, obesity, low levels of
Table 2 Standardized rates and standardized rate ratio between sexes
Women Men
Indicators standardized ratesa (95 % CI) standardized ratesa (95 % CI) RRb (95 % CI)
Participants from successfully-invited population 67.14 (66.67-67.62) 61.69 (61.23-62.16) 0.91 (0.91-0.92)
Lesions among participants 15.69 (14.82-16.61) 48.50 (46.84-50.20) 3.07 (2.96-3.17)
Cancer among participants 2.42 (2.08-2.80) 5.79 (5.22-6.41) 2.34 (2.12-2.58)
Stage III/IV cancer among participants 0.82 (0.63-1.05) 1.76 (1.45-2.12) 2.03 (1.69-2.43)
Colonoscopies performed after + FOBT 92.07 (88.99-95.23) 92.95 (90.52-95.44) 1.01 (0.99-1.04)
Lesions identified among colonoscopy patients 35.30 (33.33-37.36) 56.11 (54.17-58.10) 1.62 (1.56-1.67)
Lesions, out of those with + FOBT 32.50 (30.68-34.40) 52.19 (50.39-54.04) 1.63 (1.58-1.69)
aRates per 1000 for lesions, cancer and cancer stage; percentage for participants, colonoscopy after + FOBT and colonoscopy patients with lesions
bStandardized rate ratio for men/women
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Table 3 PPV of the test, participation, lesion and colonoscopy rates following positive test result, by age group
Women Men
Age groups successfully-
invited
population
no. of
participants
% participation OR (95 % CI) Age
groups
successfully-
invited
population
no. of
participants
% participation OR (95 % CI)
50-54 37379 24609 65.84 1.00 50-54 36221 21033 58.07 1.00
55-59 27637 19375 70.11 1.22 (1.18-1.26) 55-59 26324 16692 63.41 1.25 (1.21-1.29)
60-64 28760 20434 71.05 1.27 (1.23-1.32) 60-64 26866 18144 67.54 1.50 (1.45-1.55)
64-69 18758 12635 67.36 1.07 (1.03-1.11) 64-69 17175 11457 66.71 1.45 (1.40-1.51)
p < 0.001 p < 0.001
Age groups no. of
participants
no. of
lesions
(premal. +
malignant)
rate of
lesions
(premal. +
malignant)
among
participantsa
OR (95 % CI) Age groups no. of
participants
no. of
lesions
(premal. +
malignant)
rate of
lesions
(premal. +
malignant)
among
participants
OR (95 % CI)
50-54 24609 302 12.27 1.00 50-54 21033 593 28.19 1.00
55-59 19375 273 14.09 1.15 (0.97-1.35) 55-59 16692 777 46.55 1.7 (1.51-1.88)
60-64 20434 357 17.47 1.43 (1.22-1.66) 60-64 18144 1058 58.31 2.1 (1.93-2.37)
64-69 12635 257 20.34 1.66 (1.41-1.97) 64-69 11457 799 69.74 2.6 (2.31-2.87)
p < 0.001 p < 0.001
Age groups no. of
participants
no. of
malignant
lesions
rate of
malignant
lesions
among
participantsa
OR (95 % CI) Age groups no. of
participants
no. of
malignant
lesions
rate of
malignant
lesions
among
participants
OR (95 % CI)
50-54 24609 38 1.54 1.00 50-54 21033 47 2.23 1.00
55-59 19375 37 1.91 1.24 (0.78-1.95) 55-59 16692 77 4.61 2.07 (1.45-3.00)
60-64 20434 59 2.89 1.87 (1.25-2.83) 60-64 18144 119 6.56 2.97 (2.13-4.20)
64-69 12635 47 3.72 2.40 (1.56-3.70) 64-69 11457 126 11.00 5.02 (3.62-7.10)
p < 0.001 p < 0.001
Age groups no. of
participants
no. of
carcinomas
stage III/IV
no. of
carcinomas
stage III/IV
OR (95 % CI) Age groups no. of
participants
no. of
carcinomas
stage III/IV
no. of
carcinomas
stage III/IV
OR (95 % CI)
50-54 24609 16 0.65 1.00 50-54 21033 10 0.48 1.00
55-59 19375 15 0.77 1.19 (0.58-2.41) 55-59 16692 19 1.14 2.40 (1.14-5.37)
60-64 20434 22 1.08 1.65 (0.87-3.19) 60-64 18144 37 2.04 4.33 (2.24-9.20)
64-69 12635 10 0.79 1.20 (0.52-2.61) 64-69 11457 44 3.84 8.23 (4.32-17.34)
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Table 3 PPV of the test, participation, lesion and colonoscopy rates following positive test result, by age group (Continued)
p = 0.488 p < 0.001
Age groups people
with + FOBT
people
who had
colonoscopy
% colonoscopies OR (95 % CI) Age
groups
people
with + FOBT
people
who had
colonoscopy
% colonoscopies OR (95 % CI)
50-54 955 881 92.25 1.00 50-54 1360 1259 92.57 1.00
55-59 827 773 93.47 1.17 (0.82-1.69) 55-59 1458 1363 93.48 1.17 (0.87-1.57)
60-64 1083 991 91.51 0.90 (0.65-1.23) 60-64 1871 1739 92.94 1.06 (0.81-1.39)
64-69 785 720 91.72 0.91 (0.64-1.29) 64-69 1339 1266 94.55 1.40 (1.03-1.92)
p = 0.446 p = 0.150
Age groups people
who had
colonoscopy
no. of
lesions
(premal. +
malignant)
% lesions
found in
colonoscopy
OR (95 % CI) Age groups people
who had
colonoscopy
no. of lesions
(premal. +
malignant)
% lesions
found in
colonoscopy
OR (95 % CI)
50-54 881 302 34.28 1.00 50-54 1259 593 47.10 1.00
55-59 773 273 35.32 1.05 (0.85-1.28) 55-59 1363 777 57.01 1.49 (1.27-1.73)
60-64 991 357 36.02 1.08 (0.89-1.30) 60-64 1739 1058 60.84 1.75 (1.51-2.02)
64-69 720 257 35.69 1.07 (0.87-1.31) 64-69 1266 799 63.11 1.92 (1.64-2.25)
p = 0.883 p < 0.001
Age groups people
with + FOBT
no. of
lesions
(premal. +
malignant)
PPV OR (95 % CI) Age groups people
with + FOBT
no. of
lesions
(premal. +
malignant)
PPV OR (95 % CI)
50-54 955 302 31.62 1.00 50-54 1360 593 43.60 1.00
55-59 827 273 33.01 1.06 (0.87-1.30) 55-59 1458 777 53.29 1.48 (1.27-1.71)
60-64 1083 357 32.96 1.06 (0.88-1.28) 60-64 1871 1058 56.55 1.69 (1.46-1.94)
64-69 785 257 32.74 1.06 (0.86-1.29) 64-69 1339 799 59.67 1.91 (1.64-2.23)
p = 0.919 p < 0.001
OR Odds ratios adjusted by DI quintile, CI Confidence interval; p: significance value of the likelihood ratio test for the association between age and outcome variable
arates per 1000 inhabitants
H
urtado
et
al.BM
C
Public
H
ealth
 (2015) 15:1021 
Page
8
of
14
Table 4 PPV of the test, standardized participation, lesion and colonoscopy following positive test result, by socioeconomic stratum of place of residence
Women Men
DI quintile successfully-
invited
population
no. of
participants
% participation OR (95 % CI) DI quintile successfully-
invited
population
no. of
participants
% participation OR (95 % CI)
I (least disadvantaged) 26193 17228 65.73 1.00 I (least
disadvantaged)
23947 14743 61.87 1.00
II 24373 17026 69.89 1.21 (1.16-1.25) II 23373 15079 64.91 1.14 (1.10-1.19)
III 22632 16160 71.46 1.30 (1.25-1.35) III 21440 14086 66.07 1.20 (1.15-1.25)
IV 19927 13819 69.30 1.17 (1.13-1.22) IV 19343 12349 64.07 1.10 (1.06-1.14)
V (most disadvantaged) 19409 12820 66.06 1.01 (0.97-1.05) V (most
disadvantaged)
18483 11069 60.25 0.93 (0.90-0.97)
p < 0.001 p < 0.001
DI quintile no. of
participants
no. of
lesions
(premal. +
malignant)
rate of
lesions
(premal. +
malignant)
among
participantsa
OR (95 % CI) DI quintile no. of
participants
no. of
lesions
(premal. +
malignant)
rate of
lesions
(premal. +
malignant)
among
participants
OR (95 % CI)
I (least disadvantaged) 17228 255 15.39 1.00 I (least
disadvantaged)
14743 594 40.99 1.00
II 17026 246 14.61 0.97 (0.81-1.16) II 15079 705 48.73 1.18 (1.06-1.32)
III 16160 258 16.12 1.07 (0.90-1.27) III 14086 703 50.76 1.25 (1.12-1.40)
IV 13819 233 16.99 1.11 (0.93-1.33) IV 12349 617 49.83 1.23 (1.10-1.38)
V (most disadvantaged) 12820 197 15.40 1.01 (0.84-1.22) V (most
disadvantaged)
11069 608 55.68 1.38 (1.23-1.55)
p = 0.600 p = 0.002 RII 1.37 (1.21-1-55)
DI quintile no. of
participants
no. of
malignant
lesions
rate of
malignant
lesions
among
participantsa
OR (95 % CI) DI quintile no. of
participants
no. of
malignant
lesions
rate of
malignant
lesions
among
participants
OR (95 % CI)
I (least disadvantaged) 17228 38 2,25 1,00 I (least
disadvantaged)
14743 78 5,46 1,00
II 17026 37 2,24 0,98 (0.62-1.54) II 15079 85 6,14 1,08 (0.80-1.48)
III 16160 38 2,37 1,05 (0.67-1.65) III 14086 93 6,89 1,25 (0.92-1.69)
IV 13819 31 2,35 0,97 (0.60-1.56) IV 12349 45 3,60 0,66 (0.45-0.95)
V (most disadvantaged) 12820 37 2,90 1,25 (0.79-1.97) V (most
disadvantaged)
11069 68 6,37 1,14 (0.82-1.58)
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Table 4 PPV of the test, standardized participation, lesion and colonoscopy following positive test result, by socioeconomic stratum of place of residence (Continued)
p = 0.824 p = 0.006
DI quintile no. of
participants
no. of
carcinomas
stage III/IV
no. of
carcinomas
stage III/IV
OR (95 % CI) DI quintile no. of
participants
no. of
carcinomas
stage III/IV
no. of
carcinomas
stage III/IV
OR (95 % CI)
I (least disadvantaged) 17228 10 0.70 1.00 I (least
disadvantaged)
14743 24 1.97 1.00
II 17026 14 0.84 1.27 (0.59-2.76) II 15079 27 2.03 1.00 (0.59-1.69)
III 16160 10 0.67 0.97 (0.42-2.22) III 14086 20 1.52 0.75 (0.41-1.32)
IV 13819 12 0.89 1.23 (0.54-2.76) IV 12349 12 0.94 0.49 (0.24-0.93)
V (most disadvantaged) 12820 13 0.99 1.44 (0.65-3.20) V (most
disadvantaged)
11069 22 2.13 1.02 (0.58-1.77)
p = 0.853 p = 0.137
DI quintile people
with + FOBT
people
who had
colonoscopy
% colonoscopies OR (95 % CI) DI quintile people
with +
FOBT
people
who had
colonoscopy
% colonoscopies OR (95 % CI)
I (least disadvantaged) 773 688 89.07 1.00 I (least
disadvantaged)
1168 1056 90.51 1.00
II 789 723 91.64 1.34 (0.96-1.89) II 1295 1205 92.96 1.41 (1.06-1.89)
III 735 685 93.45 1.68 (1.17-2.44) III 1292 1227 94.89 2.01 (1.47-2.77)
IV 688 647 93.99 1.94 (1.32-2.88) IV 1154 1102 95.60 2.25 (1.61-3.18)
V (most disadvantaged) 665 622 93.65 1.78 (1.22-2.63) V (most
disadvantaged)
1119 1037 92.51 1.33 (0.99-1.80)
p = 0.003 p = <0.001
DI quintile people
who had
colonoscopy
no. of
lesions
(premal. +
malignant)
% lesions
found in
colonoscopy
OR (95 % CI) DI quintile people
who
had
colonoscopy
no. of
lesions
(premal. +
malignant)
% lesions
found in
colonoscopy
OR (95 % CI)
I (least disadvantaged) 688 255 37.01 1.00 I (least
disadvantaged)
1056 594 55.46 1.00
II 723 246 33.88 0.88 (0.70-1.09) II 1205 705 57.23 1.10 (0.93-1.30)
III 685 258 37.72 1.03 (0.82-1.27) III 1227 703 56.27 1.05 (0.88-1.24)
IV 647 233 36.14 0.95 (0.76-1.19) IV 1102 617 54.97 0.99 (0.83-1.17)
V (most disadvantaged) 622 197 31.01 0.79 (0.63-0.99) V (most
disadvantaged)
1037 608 57.61 1.09 (0.91-1.30)
p = 0.143 p = 0.669
DI quintile people
with +
FOBT
no. of
lesions
PPV OR (95 % CI) DI quintile people
with +
FOBT
no. of
lesions
PPV OR (95 % CI)
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Table 4 PPV of the test, standardized participation, lesion and colonoscopy following positive test result, by socioeconomic stratum of place of residence (Continued)
(premal. +
malignant)
(premal. +
malignant)
I (least disadvantaged) 773 255 32.97 1.00 I (least
disadvantaged)
1168 594 50.18 1.00
II 789 246 31.05 0.92 (0.74-1.14) II 1295 705 53.25 1.16 (0.99-1.36)
III 735 258 35.26 1.10 (0.89-1.36) III 1292 703 53.49 1.16 (0.99-1.36)
IV 688 233 33.98 1.04 (0.83-1.29) IV 1154 617 52.57 1.11 (0.94-1.31)
V (most disadvantaged) 665 197 29.00 0.85 (0.68-1.07) V (most
disadvantaged)
1119 608 53.29 1.14 (0.96-1.34)
p = 0.197 p = 0.349
OR Age-adjusted odds ratios, CI Confidence interval
DI quintile: Socioeconomic deprivation index quintile proposed by the MEDEA project; p: significance value of the likelihood ratio test for the association between DI and outcome variable; RII: relative index
of inequality
aage-standardized rates per 1000 inhabitants (reference population Basque Country 2011)
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physical activity or non-adherence to a Mediterranean
diet, as well as greater psychological stress due to socio-
economic status, which may lead to increased susceptibil-
ity to disease in general. Moreover, opportunistic CRC
screening, which is performed with greater frequency in
higher social classes, leads to a higher percentage of can-
cers avoided in this group, due to lesions being detected
in premalignant phases [45, 47, 48]. For the European
studies that show a lower incidence of CRC in the lowest
socioeconomic strata, it is argued that in addition to a
lesser influence of the differential CRC screening effect in
Europe, people also have better dietary habits or adhere
more closely to a Mediterranean diet, especially in rural
areas and southern countries [45–46].
In the Basque Country, according to the 2013 Basque
Health Survey, the proportion of men who are smokers,
obese or sedentary increases with decreasing social class
or education level. Fruit and vegetable intake is also
lower in the lower socioeconomic strata, while it seems
that the only risk factor that occurs in greater propor-
tion in the higher strata, is that of dangerously high
levels of alcohol consumption [49]. The higher preva-
lence of risk factors in male members of the most disad-
vantaged groups in the Basque Country may partly
account for the results obtained in this study. But not so
in the case of women, where no inverse association
between social class and lesion detection exists, findings
similar to those published by Oliphant et al. with data
from a CRC screening programme in the west of
Scotland [50]. The authors of the Scottish study could
not provide a clear explanation for this differential be-
haviour between the sexes, although they raised a num-
ber of possible reasons, including the possibility of some
differences in risk factors between the sexes, such as ex-
cessive alcoholism in men or less physical activity in
women. In the present study, the 2013 Basque Health
Survey reveals that in the Basque Country while to-
bacco consumption among men increases as social
class decreases, no pattern can be seen in women from
the age of 45. Nevertheless, the highest prevalence of
other risk factors occurs in the most disadvantaged so-
cial groups, meaning that the social inequalities in the
screening results cannot be explained through these
risk factors alone.
Limitations of this study include the fact that, during
the study period (2009–2011), the centres participating
in the CRC screening programme were not chosen at
random, but by the ability of their corresponding referral
hospitals to assume the task of performing colonoscopy
for screening purposes. This does not preclude broad
representation from all socioeconommic groups, since
all three provinces are represented and more than
200,000 eligible individuals were included, representing
about 50 % of the target population (not taking
exclusion criteria into account), with sufficient numbers
of people in all relevant variables. It seems, therefore,
that the included target population would have similar
differential characteristics to the rest of the hypothetical
target population of the Basque Country. Further ana-
lysis should nevertheless be performed on the definitive
data covering 100 % of the population (2014), to assess
whether the behaviour is reproduced throughout the
entire target population. Moreover, as mentioned above,
the non-participant population would most likely have
different clinical, social and cultural characteristics to
the participating population, and their inclusion might
modify the results of this study. Studies that included
this non-participant population would be necessary to
clarify this question. Finally, using aggregated census
tract data to assign socioeconomic status to each indi-
vidual may lead to incorrect classification of the socio-
economic level in some cases, altering the results to a
greater or lesser extent. Numerous studies have, how-
ever, demonstrated the use of socioeconomic data of
small areas as an approximation to the socioeconomic
status of individuals in order to detect health inequalities
[51–54]. The absence of individual socioeconomic data
has thus been overcome by allocating to subjects the
characteristics of the census tract of residence.
Conclusions
Gender and socioeconomic inequalities are relevant in
CRC screening programmes. Both influence participation
in the CRC programme and the number of lesions found.
Any public health programme is morally and ethically
obliged to strive for equity and also improve programme
effectiveness. Achieving a CRC screening programme
that can improve participation of men and socially dis-
advantaged groups would make the programme more ef-
fective, and also more equitable. In this way, the Basque
Country authorities have included indicators related to
screening inequities in general strategies and annual
evaluations. Some initiatives to increase men’s participa-
tion have been carrying out involving civil associations,
factory managers and Primary Care Centres focused in
information improvements (video, web-site, training and
open meetings), but others related to tackling root
causes of hegemonic masculinity in our societies should
also need to develop. Regarding most disadvantaged
populations, specific qualitative studies will be necessary,
so that their main barriers to participating in the
programme are adequately understood.
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